Annals of Emergency Medicine
Volume 53, Issue 3 , Pages 329-338 , March 2009

Clevidipine, an Intravenous Dihydropyridine Calcium Channel Blocker, Is Safe and Effective for the Treatment of Patients With Acute Severe Hypertension

Presented as a poster at the American College of Emergency Physicians 2007 Scientific Assembly, October 2007, Seattle, WA.

  • Charles V. Pollack, MD, MA

      Affiliations

    • Department of Emergency Medicine, Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationAddress for correspondence: Charles V. Pollack, MA, MD, Department of Emergency Medicine, Pennsylvania Hospital, 800 Spruce Street, 2 Pine East, Philadelphia, PA 19107; 215-829-7549, fax 610-687-0137
    • ,
  • Joseph Varon, MD

      Affiliations

    • The University of Texas Health Science Center at Houston, The University of Texas Medical Branch at Galveston, St. Luke's Episcopal Hospital/Texas Heart Institute, Houston, TX
    • ,
  • Norman A. Garrison, MD

      Affiliations

    • Jackson Hospital, Montgomery, AL
    • ,
  • Ramin Ebrahimi, MD

      Affiliations

    • University of California Los Angeles and VA Greater Los Angeles Healthcare Center, Los Angeles, CA
    • ,
  • Lala Dunbar, MD

      Affiliations

    • Louisiana State University Health Science Center, New Orleans, LA
    • ,
  • W. Frank Peacock IV, MD

      Affiliations

    • The Cleveland Clinic, Department of Emergency Medicine, Cleveland, OH

Received 11 January 2008 ,Revised 11 March 2008 ,Accepted 7 April 2008.

References 

  1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics 2008 update (A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee). Circulation http://www.circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.107.187998v1Accessed May 6, 2008
  2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199–206
  3. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949–1962
  4. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68:283–297
  5. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
  6. Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24:135–146
  7. Feldstein C. Management of hypertensive crises. Am J Ther. 2007;14:135–139
  8. Granger C, Katz J, Kleinschmidt K, et al. Acute severe hypertension is associated with high morbidity and mortality: interim results from the STAT registry. Poster presented at: Society of Critical Care Medicine (SCCM) 37th Annual Critical Care Congress; February 2-8, 2008; Honolulu, HI.
  9. Dasta JF, Bollinger JE, Gerlach AT, et al. National survey of acute hypertension management [abstract]. Crit Care Med. 2007;35(12 suppl):A89
  10. Oparil S, Aronson S, Deeb GM, et al. Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens. 1999;12:653–664
  11. Curran MP, Robinson DM, Keating GM. Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs. 2006;66:1755–1782
  12. Ericsson H, Fakt C, Jolin-Mellgård Å, et al. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol. 1999;47:531–538
  13. Ericsson H, Bredberg U, Eriksson U, et al. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology. 2000;92:993–1001
  14. Kieler-Jensen N, Jolin-Mellgård Å, Nordlander M, et al. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol Scand. 2000;44:186–193
  15. Nordlander M, Sjoquist PO, Ericsson H, et al. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. 2004;22:227–250
  16. Schwieler JH, Ericsson H, Lofdahl P, et al. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol. 1999;34:268–274
  17. Bailey JM, Lu W, Levy JH, et al. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology. 2002;96:1086–1094
  18. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care. 2003;7:374–384
  19. Gilmore RM, Miller SJ, Stead LG. Severe hypertension in the emergency department patient. Emerg Med Clin North Am. 2005;23:1141–1158
  20. Levy JH, Mancao MY, Gitter R, et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. 2007;105:918–925
  21. Smith WB, Marbury TC, Komjathy SF, et al. The pharmacokinetics and pharmacodynamics of clevidipine after prolonged continuous infusion in patients with essential hypertension [abstract]. Pharmacotherapy. 2007;27:280–281
  22. Zhang JG, Dehal SS, Ho T, et al. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81. Drug Metab Dispos. 2006;34:734–737
  23. Brooks TW, Finch CK, Lobo BL, et al. Blood pressure management in acute hypertensive emergency. Am J Health Syst Pharm. 2007;64:2579–2582
  24. Hirschl MM, Binder M, Bur A, et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Med. 1997;23:885–888
  25. Jivraj S, Mazer CD, Baker AJ, et al. Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage. Can J Anesth. 2006;53:678–683
  26. Singla N, Warltier DC, Lumb PD, et al. Clevidipine is effective in rapidly controlling elevated blood pressure postoperatively in cardiac surgery patients [abstract]. Anesthesiology. 2005;103:A292

 Supervising editor: Rita K. Cydulka, MD, MS

 Author contributions: All authors contributed to the development of the study protocol, enrolled patients, and participated in data analysis and drafting of the article. CP and FP take responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. Funding for this study was provided by The Medicines Company, Parsippany, NJ. Drs. Pollack, Varon, and Peacock have served as consultants for The Medicines Company.

 Publication dates: Available online June 5, 2008.

 Reprints not available from the authors.

PII: S0196-0644(08)00728-2

doi: 10.1016/j.annemergmed.2008.04.025

Annals of Emergency Medicine
Volume 53, Issue 3 , Pages 329-338 , March 2009

Article Tools

* Image Usage & Resolution